Annexon Ownership | Who Owns Annexon?
Annexon Ownership Summary
Annexon is owned by 78.79% institutional investors, 0.50% insiders, and 20.72% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 6.89% of ANNX shares. BB Biotech AG Ord is the top mutual fund, with 4.88% of its assets in Annexon shares.
ANNX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Annexon | 78.79% | 0.50% | 20.72% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 8.45M | 6.89% | $41.40M |
| Fmr | 8.30M | 6.77% | $40.67M |
| Alerce investment management | 7.41M | 6.04% | $36.29M |
| Bvf inc/il | 7.00M | 5.71% | $34.30M |
| Blackrock | 6.59M | 5.37% | $32.28M |
| Redmile group | 6.43M | 5.24% | $31.49M |
| Point72 asset management | 5.99M | 4.88% | $29.35M |
| Bellevue group | 5.16M | 4.20% | $25.27M |
| Vanguard group | 4.56M | 3.71% | $22.33M |
| Woodline partners lp | 4.07M | 3.32% | $19.95M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alerce investment management | 7.41M | 71.13% | $36.29M |
| Bain capital life sciences investors | 8.45M | 4.55% | $41.40M |
| Redmile group | 6.43M | 1.90% | $31.49M |
| Tfg asset management gp | 1.26M | 1.54% | $6.16M |
| Bvf inc/il | 7.00M | 0.96% | $34.30M |
| Logos global management lp | 1.50M | 0.59% | $7.35M |
| Gmt capital | 2.94M | 0.53% | $14.41M |
| Rhenman & partners asset management ab | 900.00K | 0.42% | $4.41M |
| Bellevue group | 5.16M | 0.41% | $25.27M |
| Ghost tree capital | 214.50K | 0.33% | $1.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bellevue group | 5.16M | 0.41% | 2.98M |
| Woodline partners lp | 4.07M | 0.19% | 2.07M |
| Candriam s.c.a. | 2.05M | 0.06% | 2.05M |
| Blackrock | 6.59M | 0.00% | 1.54M |
| Marshall wace, llp | 1.69M | 0.01% | 1.38M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | 400.00K | 0.31% | -1.65M |
| Pictet asset management sa | - | - | -1.64M |
| Adage capital partners gp | 2.84M | 0.03% | -1.48M |
| Fmr | 8.30M | 0.00% | -1.07M |
| Polar capital | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Candriam s.c.a. | 2.05M | 0.06% | 2.05M | $10.06M |
| Tfg asset management gp | 1.26M | 1.54% | 1.26M | $6.16M |
| Rhenman & partners asset management ab | 900.00K | 0.42% | 900.00K | $4.41M |
| Readystate asset management lp | 883.45K | 0.14% | 883.45K | $4.33M |
| Mutual of america capital management | 639.57K | 0.03% | 639.57K | $3.13M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Quadrant capital group | -34.00 |
| Parallel advisors | -122.00 |
| Lindbrook capital | -290.00 |
| Sunbelt securities | -800.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 146 | -7.01% | 110,248,434 | 2.42% | 78 | 1.02% | 80 | -18.37% | 37 | 15.63% |
| Jun 30, 2024 | 157 | 16.30% | 107,640,091 | 13.59% | 87 | 1.47% | 98 | 22.50% | 32 | 14.29% |
| Mar 31, 2024 | 135 | 32.35% | 94,758,161 | 17.52% | 77 | 0.73% | 80 | 42.86% | 28 | 3.70% |
| Dec 31, 2023 | 102 | 5.15% | 80,631,348 | 50.51% | 103 | 2.04% | 56 | 30.23% | 27 | -6.90% |
| Sep 30, 2023 | 97 | -3.00% | 53,570,888 | -1.02% | 71 | 1.37% | 43 | -34.85% | 29 | 70.59% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 5.16M | 4.88% | - |
| Vanguard Total Stock Mkt Idx Inv | 3.01M | 2.85% | 179.48K |
| iShares Russell 2000 ETF | 2.47M | 2.34% | -5.54K |
| Fidelity Growth Compy Commingled Pl S | 2.39M | 2.26% | 13.38K |
| Fidelity Growth Compy Commingled Pl O | 2.37M | 2.25% | - |
| Candriam Eqs L Biotech C USD Cap | 2.19M | 2.08% | - |
| SPDR® S&P Biotech ETF | 1.95M | 1.85% | 21.58K |
| Fidelity Growth Company Fund | 1.78M | 1.69% | -3.78K |
| Fidelity Small Cap Growth | 1.33M | 1.26% | -3.48K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.30M | 1.23% | -4.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 02, 2024 | Carson William H. | - | Buy | $17.06K |
| Oct 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | $40.07K |
| Oct 01, 2024 | Carson William H. | - | Buy | $19.10K |
| Sep 19, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | $31.95K |
| Sep 12, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | $33.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | 1 |
| 2024 Q3 | 3 | 7 |
| 2024 Q2 | 3 | - |
| 2024 Q1 | - | 7 |
| 2023 Q4 | 1 | 2 |
ANNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools